Nearly 100 biotechs went public amid the industry’s IPO frenzy in 2021, driven by an influx of pandemic-driven investments. But many of those companies have little to show investors.
Elon Musk’s aerospace company is reportedly targeting a mid-June IPO because there will be a spectacular planetary alignment ...
An expected surge in public offerings means more excitement, but also more duds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results